Organisation
HIV/STI Clinic
Current researchers
1 - 10 of 20 results
- Maureen Aerts (Member)
- Ludwig Apers (Member)
- Vincent Barvaux (Member)
- Séverine Caluwaerts (Member)
- Emmanuelle Cleve (Member)
- Eva Hemelaer (Member)
- Corinne Herrijgers (Member)
- Veerle Huyst (Member)
- Ilse Kint (Member)
- Cora Lamonte (Member)
Projects
1 - 9 of 9
- Contemporary challenges in Human Immunodeficiency Virus Pre-Exposure-Prophylaxis care in BelgiumFrom15 Nov 2022 → Today
- PReventing the Emergence of untreatable STIs via radical PreventionFrom1 Jan 2021 → Today
- Ontwikkeling en evaluatie van een gecomputeriseerde interventie voor chemsex ondersteuningFrom19 Nov 2020 → 31 Dec 2021
- Chemified: pilot testing of a mobile application for chemsexcare and supportFrom20 Oct 2020 → 20 Oct 2021
- Optimise PrEP to Maximise ImpactFrom1 Jan 2019 → 31 Dec 2023
- Evaluating mHealth technology in HIV to improve Empowerment and healthcare utilisation: Research and innovation to Generate Evidence for personalised careFrom1 May 2015 → 30 Sep 2020
- Analytical treatment interruption in HIV positive patients with low viral reservoir to evaluate the potential of a functional cureFrom1 Nov 2014 → 31 Oct 2018
- Hepatitis C treatment for HIV patients in resource-poor countries: is a public health approach possibleFrom1 Jul 2014 → 31 Dec 2019
- Operational knowledge to improve HIV early diagnosis and treatment among vulnerable groups in EuropeFrom1 Apr 2014 → 30 Sep 2017
Publications
41 - 50 of 295
- Impact of diabetes on medical costs in the pre- and postoperative year of lower extremity amputations in Belgium(2024)
Authors: Patrick Lauwers, Jeroen M H Hendriks, Kristien Wouters, Johan Vanoverloop, Hervé Avalosse, Eveline Dirinck, Frank Nobels
- Current levels of drug resistance among therapy-naive HIV-infected patients have significant impact on treatment response [letter](2004)
Authors: I Derdelinckx, K Van Laethem, B Maes, Y Schrooten, S. De Wit, Eric Florence, K Fransen, S García Ribas, D Marissens, M. Moutschen, et al.
Pages: 1664-1666 - Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study)(2002)
Authors: Eric Florence, CHRISTA DREEZEN, Patrick Desmet, E Smets, K Fransen, B. Vandercam, JOLANDA PELGROM, N Clumeck, R. Colebunders
Pages: 255-262 - Systematic review on cumulative HIV viraemia among people living with HIV receiving antiretroviral treatment and its association with mortality and morbidity(2023)
Authors: Anita Mesic, Tom Decroo, Eric Florence, Koert Ritmeijer, Josefien Van Olmen, Lutgarde Lynen
- The emergence of travel-related infections in critical care units(2022)
Authors: Pieter-Jan Herten, E Vlieghe, E Bottieau, Eric Florence, Philippe G Jorens
Pages: 328-339 - Correction to: iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy(2019)
Authors: Wesley de Jong, Joeri Aerts, Sabine Allard, Christian Brander, Jozefien Buyze, Eric Florence, Eric C M van Gorp, G Vanham, Lorna Leal, Beatriz Mothe, et al.
- Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection(1994)
Authors: L Kestens, G Vanham, C Vereecken, M Vandenbruaene, G Vercauteren, Robert Colebunders, P Gigase
Pages: 436-441 - mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients(2012)
Authors: E. Van Gulck, E Vlieghe, M Vekemans, VF Van Tendeloo, A Van de Velde, E Smits, S Anguille, N. Cools, H Goossens, Liesbet Mertens, et al.
Pages: F1-F12 - Characteristics of confirmed mpox cases among clinical suspects: a prospective single-centre study in Belgium during the 2022 outbreak(2023)
Authors: Matilde Hens, Isabel Brosius, Nicole Berens-Riha, Jasmine Coppens, Liesbeth Van Gestel, Jojanneke Rutgers, C Kenyon, Patrick Soentjens, Saskia van Henten, Stefanie Bracke, et al.
Pages: 101093 - High level of macrolide resistance of Mycoplasma genitalium found among MSM at high risk for HIV in a Belgian PrEP demonstration project(2018)
Authors: Irith De Baetselier, H. Smet, Kristien Wouters, Beatrijs Vuylsteke, Thijs Reyniers, Marie Laga, Tania Crucitti
Pages: 293